Jean-Christophe Renauld, Pr

Ludwig Institute for Cancer Research
Brussels Belgium Papers:
F.105 INTERLEUKIN-22 IS A CRITICAL MEDIATOR OF VACCINE-INDUCED REDUCTION OF HELICOBACTER INFECTION IN THE MOUSE MODEL
T.75 IL-22BP is produced by EOSINOPHILS in HUMAN GUT and INHIBITS the PROTECTIVE ACTIONS of IL-22 during experimental COLITIS